Polypill eligibility and equivalent intake in a Swiss population-based study

Abstract The polypill has been advocated for cardiovascular disease (CVD) management. The fraction of the population who could benefit from the polypill in Switzerland is unknown. Assess (1) the prevalence of subjects (a) eligible for the polypill and (b) already taking a polypill equivalent; and (2...

Full description

Saved in:
Bibliographic Details
Main Authors: Julien Castioni, Nazanin Abolhassani, Peter Vollenweider, Gérard Waeber, Pedro Marques-Vidal
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/71dbf9080ab34f198653c5279a12ddc6
Tags: Add Tag
No Tags, Be the first to tag this record!